Assenagon Asset Management
COGT icon

Assenagon Asset Management’s Cogent Biosciences COGT Stock Holding History

Assenagon Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8M Buy
1,441,756
+1,146,106
+388% +$40.1M 0.07% 213
2026
Q1 		$11.4M Sell
295,650
-79,976
-21% -$2.95M 0.02% 432
2025
Q4 		$13.3M Sell
375,626
-201,378
-35% -$5.66M 0.02% 443
2025
Q3 		$8.29M Buy
577,004
+380,345
+193% +$4.51M 0.01% 524
2025
Q2 		$1.41M Sell
196,659
-277,034
-58% -$1.54M ﹤0.01% 855
2025
Q1 		$2.84M Hold
473,693
– – ﹤0.01% 665
2024
Q4 		$3.69M Sell
473,693
-133,515
-22% -$1.33M 0.01% 763
2024
Q3 		$6.56M Buy
607,208
+6,444
+1% +$62.7K 0.01% 640
2024
Q2 		$5.06M Hold
600,764
– – 0.01% 631
2024
Q1 		$4.04M Hold
600,764
– – 0.01% 656
2023
Q4 		$3.53M Sell
600,764
-8,134
-1% -$62.3K 0.01% 737
2023
Q3 		$5.94M Sell
608,898
-89,373
-13% -$1.06M 0.02% 534
2023
Q2 		$8.27M Hold
698,271
– – 0.03% 390
2023
Q1 		$7.53M Hold
698,271
– – 0.03% 457
2022
Q4 		$8.07M Sell
698,271
-290,365
-29% -$3.6M 0.03% 423
2022
Q3 		$14.8M Hold
988,636
– – 0.06% 280
2022
Q2 		$8.92M Buy
+988,636
New +$6.75M 0.03% 395

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Assenagon Asset Management's COGT Position: Q2 2026 in Review

Assenagon Asset Management increased its Cogent Biosciences (COGT) stake by 388% in Q2 2026, buying an estimated $40.1M and bringing the position to 1,441,756 shares worth $55.8M. The position accounts for 0.07% of the portfolio, ranked #213.

Assenagon Asset Management first reported a position in COGT in Q2 2022 and has held it in 17 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Assenagon Asset Management held 1,441,756 shares of Cogent Biosciences worth $55.8M as of Q2 2026.
  • Assenagon Asset Management bought 1,146,106 Cogent Biosciences shares in Q2 2026, an estimated $40.1M.
  • Cogent Biosciences made up 0.07% of Assenagon Asset Management's portfolio in Q2 2026, its #213 holding.
  • Assenagon Asset Management first reported a position in Cogent Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.